CA2625156C - Compositions d'adjuvant comprenant un sel mineral et un autre compose immunostimulateur - Google Patents

Compositions d'adjuvant comprenant un sel mineral et un autre compose immunostimulateur Download PDF

Info

Publication number
CA2625156C
CA2625156C CA2625156A CA2625156A CA2625156C CA 2625156 C CA2625156 C CA 2625156C CA 2625156 A CA2625156 A CA 2625156A CA 2625156 A CA2625156 A CA 2625156A CA 2625156 C CA2625156 C CA 2625156C
Authority
CA
Canada
Prior art keywords
antigen
adjuvant
peptide
conjugate
bay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2625156A
Other languages
English (en)
Other versions
CA2625156A1 (fr
Inventor
Ali Kandil
Olive A. James
Pele Chong
Michel H. Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Sanofi Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/261,194 external-priority patent/US6764682B1/en
Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd
Publication of CA2625156A1 publication Critical patent/CA2625156A1/fr
Application granted granted Critical
Publication of CA2625156C publication Critical patent/CA2625156C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

CA2625156A 1994-06-16 1995-06-15 Compositions d'adjuvant comprenant un sel mineral et un autre compose immunostimulateur Expired - Lifetime CA2625156C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/261,194 1994-06-16
US08/261,194 US6764682B1 (en) 1994-06-16 1994-06-16 Adjuvant compositions containing more than one adjuvant
CA002192659A CA2192659C (fr) 1994-06-16 1995-06-15 Compositions d'adjuvant comprenant un sel mineral et un autre compose immunostimulateur

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002192659A Division CA2192659C (fr) 1994-06-16 1995-06-15 Compositions d'adjuvant comprenant un sel mineral et un autre compose immunostimulateur

Publications (2)

Publication Number Publication Date
CA2625156A1 CA2625156A1 (fr) 1995-12-21
CA2625156C true CA2625156C (fr) 2012-11-13

Family

ID=39537715

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2625156A Expired - Lifetime CA2625156C (fr) 1994-06-16 1995-06-15 Compositions d'adjuvant comprenant un sel mineral et un autre compose immunostimulateur

Country Status (1)

Country Link
CA (1) CA2625156C (fr)

Also Published As

Publication number Publication date
CA2625156A1 (fr) 1995-12-21

Similar Documents

Publication Publication Date Title
EP0765163B1 (fr) Compositions d'adjuvant comprenant un sel mineral et un autre compose immunostimulateur
WJESMÜLLER et al. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope‐specific B‐, T‐helper and T‐killer cell response
US20080233143A1 (en) Adjuvanting Material
CN102448485B (zh) 免疫原性组合物及其用途
JPH0825899B2 (ja) 細菌性多糖類と免疫原性タンパク質との二価スペーサーによる安定な、共有結合された多糖―タンパク質結合体、該結合体の製造方法並びに該結合体を含む医薬組成物
CA2674269A1 (fr) Glycolipopeptides a trois composants
CN104507496B (zh) 包含与crm197载体蛋白偶联的hiv gp41肽的免疫原性化合物
EP0550599A1 (fr) Peptides destines a etre utilises dans la vaccination et dans l'induction d'anticorps neutralisants pour lutter contre le virus d'immunodeficience humaine
US6290971B1 (en) Adjuvant compositions comprising a mineral salt and another immunostimulating compound
JPH04506666A (ja) ワクチンアジュバントとしてのｌｆａ―３
US9534020B2 (en) Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide
CA2625156C (fr) Compositions d'adjuvant comprenant un sel mineral et un autre compose immunostimulateur
CS131891A3 (en) Vaccine
KR20160098161A (ko) 피. 에루기노사 백신용 합성 올리고당류
Weiß et al. Immunogenic properties of ISCOM prepared with influenza virus nucleoprotein
US20230149534A1 (en) Haptenized coronavirus spike proteins
AU2022255844A1 (en) Adjuvant activity enhancer and adjuvant composition
US6562801B1 (en) PpGpp and pppGpp as immunomodulatory agents
JP2001505763A (ja) Ｈｉｖ ｐ―１７ペプチドフラグメント、それを含有する組成物並びにその製造及び使用方法
WO2023060220A1 (fr) Méthodes d'immunisation contre le coronavirus
JPS62187499A (ja) タフトシンまたはその類似体からなる免疫調製物
CA2171531C (fr) Constructions peptidiques a ramifications multiples, utiles contre le vih
JP2002525339A (ja) ウイルス疾患のための炭水化物ワクチン
Bessler et al. Modulation of the immune system by bacterial products: Hapten-specific humoral immune responses induced by lipopeptides conjugated to T helper cell epitopes
JPH05170797A (ja) 環状ｈｉｖ主要中和決定基ペプチド

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150615